Search research articles
Contact Us
Filters
Showing results (21-30 of 22) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 22 results.
Lung Cancer (Amsterdam, Netherlands)
|
July 20, 2019
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, et al.
The Lancet. Haematology
|
May 4, 2020
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Michele Cavo, Francesca Gay, Meral Beksac, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 22) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 22 results.
Lung Cancer (Amsterdam, Netherlands)
|
July 20, 2019
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, et al.
The Lancet. Haematology
|
May 4, 2020
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Michele Cavo, Francesca Gay, Meral Beksac, et al.
Page
of 3